Bone Biologics Corp Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2016 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Bone Biologics Corp quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2016 to Q2 2024.
  • Bone Biologics Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 1.17M shares, a 244% increase year-over-year.
  • Bone Biologics Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 263K shares, a 452% increase from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 1.17M +829K +244% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 661K +594K +883% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 263K Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 3.13M +2.79M +808% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 339K -5.71K -1.66% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 67.2K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q3 2022 345K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 345K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q2 2018 4.42M +347K +8.5% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-14
Q2 2017 4.07M -34.1M -89.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q2 2016 38.2M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.